EC Number   |
Application |
Reference |
|---|
   2.4.2.38 | biotechnology |
glycoengineering: humanized N-glycosylation in plants by knock-down of plant-specific N-glycan maturation enzymes, pharmaceutical glycoprotein production in plant |
694619 |
| 2.4.2.38 | biotechnology |
pharmaceutical protein production in plant, glycoengineering: humanized N-glycosylation in plants by knock-down of plant-specific N-glycan maturation enzymes |
694620 |
| 2.4.2.38 | biotechnology |
the plant is useful for expression of human monoclonal antibodies free of zoonotic pathogens, co-expression of RNAi to block beta-1,2-xylosyltransferase and alpha-1,3-fucosyltransferase prevents unwanted plant specific N-glycosylation of the recombinant antibody proteins, overview |
676122 |
| 2.4.2.38 | medicine |
development of diagnostic and therapeutic strategies due to importance of xylose transfer in cryptococcal biology, pathogenesis and virulence |
692134 |
| 2.4.2.38 | medicine |
loss of XT1 leads to attenuation of virulence |
693051 |
| 2.4.2.38 | medicine |
the enzyme is a biomarker for myofibroblast differentiation and fibrotic development |
735595 |
| 2.4.2.38 | medicine |
xylose residues within the capsule polysaccharide are important for normal host-pathogen interaction, loss of CXT1p attenuates virulence |
693051 |
| 2.4.2.38 | synthesis |
potential of maize and the beta1,2-xylosyltransferase as a production system for heterologous glycoproteins |
676375 |
